Methylprednisolone Acetate Pharmaceutical Compositions

Abstract: A pharmaceutical aqueous suspension formulation for parenteral administration having substantially stabilized pH comprising a biologically active steroidal compound and excipients, wherein at least one of the excipient used is dried. Preferably, the biologically active compound is a steroidal compound, for instance selected from the group consisting of individually or combination of methylprednisolone, medroxyprogesterone, triamcinolone, testosterone, clostebol, estradiol, exemestane and pharmaceutically acceptable esters and salts thereof.

Patent Information

Applicants

Inventors

Specification

Documents